Uncover key drivers, emerging technologies, and competitive movements shaping the digital papanicolaou (pap) smear analyzer market from 2026–2035 with trusted insights from The Business Research Company
What long-term size projections exist for the Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market covering 2026–2035?
The artificial intelligence (AI) in in vitro diagnostics (IVD) market has experienced substantial expansion in recent years. This market is forecasted to increase from $3.04 billion in 2025 to $3.6 billion in 2026, achieving a compound annual growth rate (CAGR) of 18.4%. The historical growth can be attributed to various factors, including an elevated demand for precise diagnostics, the development of laboratory infrastructure, a growing prevalence of chronic diseases, the adoption of digital diagnostic tools, and advancements in biomarker research.
The artificial intelligence (ai) in in vitro diagnostics (ivd) market is projected to experience swift expansion over the coming years. This market is set to reach $7.01 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 18.1%. Key factors driving this growth during the forecast period include the proliferation of cloud-based diagnostic platforms, the fusion of AI with genomics, the emergence of point-of-care AI diagnostics, rising investments in personalized medicine, and a heightened need for quick and economical testing solutions. Significant trends anticipated in this period encompass AI-enabled laboratory automation, predictive diagnostics for diseases, data-driven interpretation of tests, cloud-based diagnostic platforms, and individualized patient profiling.
Access Your Free Sample Report for In-Depth Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=28120&type=smp
Which Drivers Are Impacting The Competitive Landscape Of The Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market?
The rising need for personalized medicine is projected to stimulate the growth of artificial intelligence (AI) in in vitro diagnostics (IVD) market in the future. Personalized medicine defines a healthcare strategy that tailors prevention, diagnosis, and treatment based on an individual’s genetic profile, lifestyle, and environment. This approach is gaining traction as advancements in genomic data and sequencing technologies enable more accurate, targeted, and effective treatments customized for individual patients. Artificial intelligence (AI) in in vitro diagnostics (IVD) supports personalized medicine by analyzing complex diagnostic data to pinpoint patient-specific disease patterns, which facilitates precise, timely, and customized treatment decisions. For instance, in February 2024, the Personalized Medicine Coalition, a US-based non-profit organization, reported that the FDA approved 16 new personalized treatments for rare disease patients in 2023, an increase from six in 2022. The new personalized treatments approved in 2023 also encompassed seven cancer drugs and three for other diseases and conditions. Therefore, the expanding demand for personalized medicine is fueling the growth of artificial intelligence (AI) in in vitro diagnostics (IVD) market.
What Leading Segments Are Studied In The Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market?
The artificial intelligence (ai) in in vitro diagnostics (ivd) market covered in this report is segmented –
1) By Component: Software, Hardware, Services
2) By Technology: Machine Learning, Natural Language Processing, Computer Vision, Robotics Process Automation, Deep Learning
3) By Deployment Model: Cloud-Based, On-Premise, Hybrid
4) By Application: Diagnostic Imaging, Laboratory Testing, Pathology, Genomics, Personalized Medicine
5) By End User: Hospitals And Clinics, Diagnostic Laboratories, Research Institutes, Pharmaceutical Companies, Medical Device Manufacturers
Subsegments:
1) By Software: Diagnostic Algorithms, Data Analytics Platforms, Decision Support Systems
2) By Hardware: Laboratory Instruments, Imaging Devices, Point-Of-Care Devices
3) By Services: Consulting And Implementation, Maintenance And Support, Training And Education
Which Trends Are Shaping Activity Within The Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market?
Major companies operating within the artificial intelligence (AI) in in vitro diagnostics (IVD) market are directing their efforts toward developing sophisticated solutions, particularly CE-IVDR-certified transparent AI platforms, to elevate diagnostic accuracy, streamline operational processes, and support individualized patient care. A CE-IVDR-certified transparent AI platform signifies an AI system utilized for in vitro diagnostics that adheres to EU regulatory standards and delivers clear, auditable, and comprehensible decision-making. As an example, in May 2025, Diagnostics.ai, a UK-based diagnostic testing company, launched PCR.AI, a smart solution designed to accelerate and enhance PCR diagnostics. This tool automates and speeds up the interpretation of real-time PCR diagnostics with over 99.9% accuracy. It offers transparency by explicitly demonstrating how each result is generated, ensuring regulatory compliance and strengthening clinical trust. This significantly improves laboratory efficiency, reduces errors, and supports seamless regulatory adherence for molecular diagnostics.
Which Key Players Are Driving Competition In The Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market?
Major companies operating in the artificial intelligence (ai) in in vitro diagnostics (ivd) market are Roche Diagnostics GmbH, Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Siemens Healthineers AG, Illumina Inc., Hologic Inc., Sysmex Corporation, QIAGEN N.V., Tempus Labs Inc., BillionToOne Inc., PathAI Inc., Proscia Inc., Indica Labs Inc., Visiopharm A/S, aetherAI Co. Ltd., Ibex Medical Analytics Ltd., Mindpeak GmbH, OncoHost Ltd., Qritive, Aiforia Technologies Oyj
Access The Complete Report For Deeper Market Insights:
Which Region Is Projected To Lead The Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market During The Forecast Period?
North America was the largest region in the artificial intelligence (AI) in in vitro diagnostics (IVD) market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the artificial intelligence (AI) in in vitro diagnostics (ivd) market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request Your Customized Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market Research Report for Competitive Advantage:
https://www.thebusinessresearchcompany.com/customise?id=28120&type=smp
Browse Through More Reports Similar to the Global Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market 2026, By The Business Research Company
Artificial Intelligence In The Diagnostic Global Market Report 2026
Ai In Cancer Diagnostics Global Market Report 2026
https://www.thebusinessresearchcompany.com/report/ai-in-cancer-diagnostics-global-market-report
Ai In Medical Devices Global Market Report 2026
https://www.thebusinessresearchcompany.com/report/ai-in-medical-devices-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company